Morgan Stanley raised its price target on IonQ (NYSE:IONQ | IONQ Price Prediction) to $47 from $37, while keeping an Equal Weight rating. The call arrived as part of a preview note covering another week of earnings from the semiconductors and quantum group on Monday, May 4.
The price target raised signals growing Wall Street confidence in IonQ’s commercial trajectory, even as Morgan Stanley stays neutral on near-term valuation. For prudent investors, the revised IonQ stock outlook lands just two days before the Q1 2026 results.
| Ticker | Company | Firm | Action | Old Rating | New Rating | Old Target | New Target |
|---|---|---|---|---|---|---|---|
| IONQ | IonQ | Morgan Stanley | Price Target Raised | Equal Weight | Equal Weight | $37 | $47 |
The Analyst’s Case
The Equal Weight stance reflects a balanced read on IonQ stock: bullish on the long-term quantum opportunity, neutral on the current valuation. The new $47 target sits well below the broader analyst consensus of $64.56, suggesting a more conservative posture even after the upward revision.
Morgan Stanley’s preview frames quantum computing as a category transitioning from research into early commercial deployments. IonQ sits at the center of that shift, with hyperscaler technology partnerships and government customers that have repeatedly re-rated the shares higher with each design win.
Company Snapshot
IonQ is the first public quantum computing company to exceed $100M in annual GAAP revenue. Q4 2025 revenue hit $61.89M, up 429% year over year (YoY), beating consensus of $40.26M.
Full-year 2025 revenue reached $130.02M, up 202% YoY. IonQ CEO Niccolo de Masi guided for FY2026 revenue of $225M to $245M, alongside an adjusted EBITDA loss of ($330M) to ($310M).
Strategic milestones for IonQ include a pending SkyWater Technology acquisition, an expanded QuantumBasel contract exceeding $60M over four years, a 99.99% two-qubit gate fidelity record, and selection by DARPA for the Phase B Quantum Benchmarking Initiative. These milestones underscore the company’s positioning as a full-stack quantum platform with both commercial and government traction.
Why the Move Matters Now
IONQ shares trade near $48, with a market cap around $16.94 billion. A price-to-sales ratio of 130.28x and an operating margin of -487.4% sit against revenue still small relative to the valuation, with broad commercial quantum adoption years away and intense competition from Alphabet‘s (NASDAQ:GOOGL) Google, IBM (NYSE:IBM), and Chinese state-backed efforts.
The bull case for IONQ stock rests on accelerating commercial momentum and a pure-play public profile. Analyst sentiment has tilted decisively bullish, with Northland’s bullish call on IonQ pegging shares at $55 on April 20. That tension between technology promise and valuation is precisely why Morgan Stanley holds Equal Weight rather than upgrading IonQ stock further.
What It Means for Your Portfolio
IonQ reports its Q1 2026 results on May 6 after market close. Polymarket traders currently assign a 90% probability that Ionq beats quarterly earnings, a near-term bullish signal that aligns with the analyst upgrade trend.
For prudent investors, the latest IonQ price target action warrants a closer look, though substantial cash burn, widening Adjusted EBITDA losses, and SkyWater integration risk argue for moderate position sizing. The stock’s beta of 3.052 reinforces that volatility remains elevated.
Watch for whether Q1 revenue, fresh partnership announcements, government contracts, and quantum benchmarking progress sustain the re-rating that has carried IonQ shares 56% higher over the past year. Sustained execution on these fronts will determine whether the Equal Weight rating eventually shifts to Overweight.
Top Gaining Stocks
Top Losing Stocks